Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO 
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO 
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges 
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals 
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver 
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns 
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting 
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank 
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion 
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom 
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows 
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks 
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips 
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility 
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed 
Want to cut your energy bills? Here’s how five experts are doing it 
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook 
SAN FRANCISCO, March 08, 2016 -- Today Zephyr Health, the leading Insights-as-a-Service company, released a report that reveals a largely untapped opportunity for sales teams in Life Sciences companies; integrating global health data and predictive insights into their commercial efforts. This latest report, “Navigating your way to insights-driven customer relationships,” published in conjunction with pharmaphorum, found that the majority of both management and frontline staff see current Customer Relationship Management (CRM) systems as a valuable tool for managing activities and customers, yet to date has not helped field teams find actions for sales strategy and planning.
"Bringing predictive capabilities and insights into customer engagement strategies and solutions is a nascent but growing opportunity for Life Sciences companies to improve sales effectiveness,” said Lance Scott, chief executive officer, Zephyr Health. “We consistently hear from our customers that they want more from their existing systems, and they recognize the immense value in having market and customer intelligence integrated into their CRM for competitive advantage.”
The “Navigating Your Way to Insights-Driven Customer Relationships” survey assessed 107 frontline sales and management staff to determine where the Life Sciences industry is in its own journey of improving customer engagement. The final report provides insights and recommendations to transform customer engagement and put forward a more proactive and predictive sales strategy. For more information, download a copy of the Zephyr Health report.
About Zephyr Health
Zephyr Health is the leading insights-as-a-service company harnessing the power of the global health data to address critical business and patient needs. Zephyr Illuminate™ helps Life Sciences companies - pharmaceutical, biotech and medical device –make confident decisions faster across the entire product lifecycle with precise and predictive insights. From pre-launch to product maturity, our solutions connect data from thousands of sources across the global healthcare ecosystem to produce deep, predictive insights that our customers use to instrument their business and dramatically improve product lifecycle performance. Zephyr Health's customers include 4 of the Top 10 Pharmaceutical companies, 2 of the Top 10 Biotech Companies and 2 of the Top 10 Medical Device companies.
Zephyr Health is a privately held company headquartered in San Francisco with offices in London, UK, and Pune, India. Zephyr Health is venture backed by Google Ventures, Kleiner Perkins Caufield & Byers and Icon Ventures. For more information, please visit: www.zephyrhealth.com.
Media Contact: Zephyr Health Global Communications [email protected]
